Buffered Penicillin G Potassium
Product Images NDC 51662-1436

11 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Buffered Penicillin G Potassium (NDC 51662-1436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clinical 1 (Clincial 1)

Clinical 1 (Clincial 1)
A data table titled 'Table 1 Zone Diameter Interpretive Standards (nearest whole mm)' presenting susceptibility breakpoints for four microorganisms: Staphylococci, N. gonorrhoeae, L. monocytogenes, and Non-enterococcal streptococci. The table shows zone diameter criteria in millimeters for categorizing bacterial susceptibility as Susceptible, Moderately Susceptible, or Resistant.*
FDA Label Image

Clinical 2 (Clinical 2)

Clinical 2 (Clinical 2)
A data table showing antimicrobial susceptibility testing results for Staphylococcus aureus ATCC 25923, with a zone diameter range of 26 to 37 millimeters.*
FDA Label Image

Clinical 3 (Clinical 3)

Clinical 3 (Clinical 3)
A data table titled 'Table 2 MIC Interpretive Standards (mcg/mL)' showing susceptibility breakpoints for five bacteria: Staphylococci, N. gonorrhoeae, L. monocytogenes, Non-enterococcal streptococci, and Pneumococci. Columns categorize susceptibility as Susceptible, Moderately Susceptible, and Resistant with corresponding MIC values listed.*
FDA Label Image

Clinical 4 (Clinical 4)

Clinical 4 (Clinical 4)
A data table showing the minimum inhibitory concentration (MIC) values for two organisms: Staphylococcus aureus ATCC 29213 with an MIC range of 0.2 to 1 mcg/mL, and Enterococcus faecalis ATCC 29212 with an MIC range of 1 to 4 mcg/mL.*
FDA Label Image

Dosage (Dosage 1)

Dosage (Dosage 1)
A dosage table for Buffered Penicillin G Potassium from HF Acquisition Co LLC, DBA HealthFirst. It lists clinical indications such as serious infections, anthrax, tetanus, diphtheria, meningitis, syphilis, and others, alongside their recommended dosage in units per day or divided doses, with duration where applicable. Footnotes describe administration frequency based on half-life and specific infection types.*
FDA Label Image

Dosage 2 (Dosage 2)

Dosage 2 (Dosage 2)
A table presenting clinical indications and corresponding dosage guidelines for Buffered Penicillin G Potassium, including treatment for serious infections, meningitis, arthritis, endocarditis, syphilis, diphtheria, and rat-bite or Haverhill fever. Dosages are detailed by weight, units per kilogram, frequency, and duration based on specific infections.*
FDA Label Image

Dosage 3 (Dosage 3)

Dosage 3 (Dosage 3)
A data table showing approximate desired concentrations of Buffered Penicillin G Potassium in units/mL with corresponding approximate volumes for 1,000,000 units, solvent volumes for 5,000,000 units, and infusion volumes for 20,000,000 units in mL. The table organizes dosing preparation information across different concentrations.*
FDA Label Image

Indications (Indications 1)

Indications (Indications 1)
A data table listing clinical indications alongside their corresponding infecting organisms. Conditions include septicemia, pneumonia, anthrax, botulism, diphtheria, syphilis, meningococcal meningitis, and various bacterial infections, matched with pathogens such as Streptococcus pyogenes, Bacillus anthracis, Clostridium species, Corynebacterium diphtheriae, Treponema pallidum, and others. Some notes explain treatment specifics related to penicillin susceptibility.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
Buffered Penicillin G Potassium for Injection, USP 5,000,000 Units vial label with manufacturer Sandoz logo. The vial contains a powder for reconstitution and use by intramuscular or intravenous injection. The label includes product NDC 0781-6135-94 and states distribution by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of the active ingredient in BUFFERED PENICILLIN G POTASSIUM, showing molecular formula C16H17KN2O4S and molecular weight 372.48. The diagram illustrates the chemical bonds and functional groups of the molecule.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
The label for Buffered Penicillin G Potassium for Injection, USP, shows 5,000,000 units strength intended for IM or IV use. The label highlights the product name, dosage strength, and that it is by Sandoz. It provides preparation instructions with dilution volumes and final concentrations. The label includes NDC 0781-6135-94 and manufacturer details with storage instructions and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.